[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@AcumenPharm](/creator/twitter/AcumenPharm) "Exciting news from Acumen: Weve entered a strategic collaboration option and license agreement with JCR Pharmaceuticals to develop a novel Alzheimers therapy using their proprietary J-Brain Cargo platform. Learn more in our joint press release:"  [@AcumenPharm](/creator/x/AcumenPharm) on [X](/post/tweet/1945843933474357630) 2025-07-17 13:52:00 UTC XXX followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@AcumenPharm
"Exciting news from Acumen: Weve entered a strategic collaboration option and license agreement with JCR Pharmaceuticals to develop a novel Alzheimers therapy using their proprietary J-Brain Cargo platform. Learn more in our joint press release:" @AcumenPharm on X 2025-07-17 13:52:00 UTC XXX followers, XX engagements
/creator/twitter::1440022980487225348/posts